660P Phase III CLEAR trial in advanced renal cell carcinoma (aRCC): Outcomes in subgroups and toxicity update. - Choueiri, T.K.; Eto, M.; Kopyltsov, E.; Rha, S.Y.; Porta, C.G.; Motzer, R.; Grünwald, V.; Hutson, T.E.; Méndez-Vidal, M.J.; Hong, S-H.; Winquist, E.; Goh, J.C.H.; et al. (Annals of Oncology, 2021)